BibbInstruments

BiBBInstruments operates in the medical technology sector. The company develops biopsy instruments based on its own technology platform. The technology is mainly used in specialist healthcare and surgical departments in the treatment of various forms of cancer. The products are sold as disposable instruments with a developed drilling function and are used at the diagnostic stage. The company was founded in 2013 and is headquartered in Lund.

Quotes for BibbInstruments

Board

CEO

  • Fredrik Lindblad

Chairperson of the Board

  • Erik von Schenck

Board

  • Charles Walther
  • Kristian Waldeck
  • Sara Lindroth
Articles of association

Videos

1 / 2
CompanyPresentation BIBBInstruments strävar efter tillväxt hos både nya och befintliga kunder
BIBBInstrument går in i kommersialiseringsfas
** Powered by Modular Finance
*Powered by Modular Finance
Key Numbers
2026-03-31 2025-12-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Number of months that the report spans Q1 3 Months 2025 Q4 3 Months Q3 3 Months Q2 3 Months Q1 3 Months 2024
Total revenue MSEK 0.11 0.40 0.25 0.11 0.00 0.04 0.00
Earnings before interest and tax MSEK -4.80 -14.67 -5.07 -2.85 -3.89 -2.86 -12.81
Profit before tax MSEK -4.80 -14.61 -5.06 -2.85 -3.81 -2.89 -12.71
Net profit MSEK -4.80 -14.61 -5.06 -2.85 -3.81 -2.89 -12.71
Earnings per share SEK -0.12 -0.37 -0.12 -0.07 -0.09 -0.08 -0.45
Dividend per share SEK 0,00 0.00 0.00 0,00 0,00 0,00 0.00
Equity MSEK 32.84 37.63 37.63 42.70 45.55 47.77 28.38
Fixed assets MSEK 0.34 0.38 0.38 0.43 0.47 0.52 0.52
Intangible assets MSEK 29.91 30.77 30.77 31.96 30.44 28.90 27.63
Current assets MSEK 5.52 9.05 9.05 12.13 17.07 20.62 5.58
Total asset MSEK 35.76 40.20 40.20 44.51 47.97 50.04 33.73
Long term liabilities MSEK 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current liabilities MSEK 2.93 2.57 2.57 1.80 2.42 2.27 5.35
Number of shares SEK 40739302.00 40739302.00 40739302.00 40739302.00 40739302.00 40224386.00 29203258.00
*Compiled data from Millistream